Nano-magnetically targeted drug delivery system for treating Atrial Fibrillation (AF)

A. Harel
NanoMed Targeting Systems Inc.,
United States

Keywords: nanotechnology, nano magnet particles, atrial fibrillation


NanoMed Targeting Systems (NTS) is developing magnetically targeted drug delivery systems for treating atrial fibrillation. This platform system is based on proprietary superparamagnetic nanoparticles attached to the payload, and its non-invasive proprietary magnetic guiding system. Atrial fibrillation (AF), the most common heart rhythm disorder, is a leading cause of strokes. With the aging population, the number of AF patients in the U.S. is expected to increase to ~16 million by 2050. AF treatment often requires expensive, long-term and risky anticoagulation to prevent strokes. Under current techniques, nearly half the patients will become drug-refractory and most will require interventions such as catheter ablations—the current standard of care. Ablations carry risks of serious complications and are very costly (5-year success